These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34374210)

  • 1. GATA2 rs2335052 and GATA2 rs78245253 single-nucleotide polymorphisms in Chinese patients with acute myelocytic leukemia.
    Fang F; Xu J; Kang Y; Ren H; Muyey DM; Chen X; Tan Y; Xu Z; Wang H
    Int J Lab Hematol; 2021 Dec; 43(6):1491-1500. PubMed ID: 34374210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer.
    Liu X; Jiang B; Wang A; Di J; Wang Z; Chen L; Su X
    PLoS One; 2015; 10(8):e0136020. PubMed ID: 26287967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia.
    Tien FM; Hou HA; Tsai CH; Tang JL; Chiu YC; Chen CY; Kuo YY; Tseng MH; Peng YL; Liu MC; Liu CW; Liao XW; Lin LI; Lin CT; Wu SJ; Ko BS; Hsu SC; Huang SY; Yao M; Chou WC; Tien HF
    Blood Cancer J; 2018 Aug; 8(9):87. PubMed ID: 30190467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients.
    Wang S; Yuan X; Liu Y; Zhu K; Chen P; Yan H; Zhang D; Li X; Zeng H; Zhao X; Chen X; Zhou G; Cao S
    J Transl Med; 2019 Mar; 17(1):101. PubMed ID: 30922329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
    Hou HA; Lin YC; Kuo YY; Chou WC; Lin CC; Liu CY; Chen CY; Lin LI; Tseng MH; Huang CF; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
    Ann Hematol; 2015 Feb; 94(2):211-21. PubMed ID: 25241285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of GATA2 and its impact on normal karyotype acute myeloid leukemia.
    Celton M; Forest A; Gosse G; Lemieux S; Hebert J; Sauvageau G; Wilhelm BT
    Leukemia; 2014 Aug; 28(8):1617-26. PubMed ID: 24514424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between DNA methyltransferases 3B gene polymorphisms and the susceptibility to acute myeloid leukemia in Chinese Han population.
    Zheng Q; Zeng TT; Chen J; Liu H; Zhang H; Su J
    PLoS One; 2013; 8(9):e74626. PubMed ID: 24069326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML).
    Zhu KW; Chen P; Zhang DY; Yan H; Liu H; Cen LN; Liu YL; Cao S; Zhou G; Zeng H; Chen SP; Zhao XL; Chen XP
    J Transl Med; 2018 Apr; 16(1):90. PubMed ID: 29631596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.
    Yuan XQ; Zhang DY; Yan H; Yang YL; Zhu KW; Chen YH; Li X; Yin JY; Li XL; Zeng H; Chen XP
    Oncotarget; 2016 Sep; 7(37):60555-60574. PubMed ID: 27528035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients.
    Cao HX; Miao CF; Yan L; Tang P; Zhang LR; Sun L
    J Transl Med; 2017 Nov; 15(1):235. PubMed ID: 29141648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA GAS5 polymorphism predicts a poor prognosis of acute myeloid leukemia in Chinese patients via affecting hematopoietic reconstitution.
    Yan H; Zhang DY; Li X; Yuan XQ; Yang YL; Zhu KW; Zeng H; Li XL; Cao S; Zhou HH; Zhang W; Chen XP
    Leuk Lymphoma; 2017 Aug; 58(8):1948-1957. PubMed ID: 27951730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.
    Greif PA; Dufour A; Konstandin NP; Ksienzyk B; Zellmeier E; Tizazu B; Sturm J; Benthaus T; Herold T; Yaghmaie M; Dörge P; Hopfner KP; Hauser A; Graf A; Krebs S; Blum H; Kakadia PM; Schneider S; Hoster E; Schneider F; Stanulla M; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK
    Blood; 2012 Jul; 120(2):395-403. PubMed ID: 22649106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
    Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
    Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia.
    Luesink M; Hollink IH; van der Velden VH; Knops RH; Boezeman JB; de Haas V; Trka J; Baruchel A; Reinhardt D; van der Reijden BA; van den Heuvel-Eibrink MM; Zwaan CM; Jansen JH
    Blood; 2012 Sep; 120(10):2064-75. PubMed ID: 22786876
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Ren H; Hong M; Feng J; Hao Z; Chen X; Liang F; Wei W; Liang X; Wang H; Chen X
    Biomol Biomed; 2024 Feb; 24(4):982-989. PubMed ID: 38416121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells.
    Katsumura KR; Ong IM; DeVilbiss AW; Sanalkumar R; Bresnick EH
    Cell Rep; 2016 Aug; 16(9):2428-41. PubMed ID: 27545880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele-specific expression of GATA2 due to epigenetic dysregulation in CEBPA double-mutant AML.
    Mulet-Lazaro R; van Herk S; Erpelinck C; Bindels E; Sanders MA; Vermeulen C; Renkens I; Valk P; Melnick AM; de Ridder J; Rehli M; Gebhard C; Delwel R; Wouters BJ
    Blood; 2021 Jul; 138(2):160-177. PubMed ID: 33831168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.
    Mosrati MA; Willander K; Falk IJ; Hermanson M; Höglund M; Stockelberg D; Wei Y; Lotfi K; Söderkvist P
    Oncotarget; 2015 Sep; 6(28):25109-20. PubMed ID: 26298771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA2 gene analysis in several forms of hematological malignancies including familial aggregations.
    Hamadou WS; Mani R; Besbes S; Bourdon V; Youssef YB; Eisinger F; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Noguchi T; Khélif A; Sobol H; Soua Z
    Ann Hematol; 2017 Oct; 96(10):1635-1639. PubMed ID: 28752392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of measurable residual disease may better predict outcomes than mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA.
    Wang J; Lu R; Wu Y; Jia J; Gong L; Liu X; Lu S; Wang Y; Yan C; Liu K; Zhang X; Xu L; Jiang Q; Zhao X; Shi H; Lai Y; Huang X; Ruan G; Jiang H
    Br J Haematol; 2020 Aug; 190(4):533-544. PubMed ID: 32090321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.